Debiopharm Innovation Fund
Debiopharm Innovation Fund appears in 1 AI deal tracked on AI Lounge in 2026.
Investing activity
Debiopharm Innovation Fund appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $26M. The rounds are mostly Series B, with a median round size of $26M. The most recent is WhiteLab Genomics (Series B, $26M, Oct 2026).
Debiopharm Innovation Fund most often invests alongside AVP, Omnes Capital, Blast Club and Yaday Health, and the companies it backs on AI Lounge are mostly in AI biotech / genomic medicine.
Deals
Frequently asked questions about Debiopharm Innovation Fund
What AI companies has Debiopharm Innovation Fund invested in?
Debiopharm Innovation Fund's AI investments include WhiteLab Genomics. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Debiopharm Innovation Fund based?
Debiopharm Innovation Fund is based in Lausanne, Switzerland.
What stage does Debiopharm Innovation Fund invest at?
In the rounds tracked on AI Lounge, Debiopharm Innovation Fund has invested at Series B, with a median round of $26M.
Who does Debiopharm Innovation Fund co-invest with?
Debiopharm Innovation Fund's most frequent co-investors on AI Lounge are AVP (1 deal), Omnes Capital (1 deal), Blast Club (1 deal) and Yaday Health (1 deal).
How can founders reach Debiopharm Innovation Fund?
Founders on AI Lounge can see Debiopharm Innovation Fund's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Debiopharm Innovation Fund to their Investor Pipeline to track the conversation.